Pharma & Biotech News Highlights Q3 2016

Pharma IQ News
Posted: 10/18/2016

Following a quarter that featured reports stating that Novartis had dramatically redistributed its cell and gene therapy unit 1 and saw the public focus turn once again to drug price hikes, Pharma IQ brings you the pharma, biotech and life sciences news highlights for Q3 of 2016.Drug PricingMylan under media eye for Epi Pen pricing: This quarter

To continue viewing this content please fill out the form below and become an Pharma IQ member.
Or if you're already a Pharma IQ member, sign in below to download.
Join

By entering in your information and submitting the form, you give the sponsor permission to contact you regarding their product and you agree to our User Agreement, Privacy Policy, and Cookie Policy.

Pharma IQ News
Posted: 10/18/2016

Pharma IQ Members

EVENTS OF INTEREST

The Hurlingham Club, London, United Kingdom
January 21 - 23, 2018
Twickenham Stadium, London, United Kingdom
January 28 - 31, 2018